STOCK TITAN

UroGen Pharma: TD Bank, TD Securities report 5.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

UroGen Pharma Ltd. (URGN) is the issuer in an amended joint beneficial-ownership statement by The Toronto-Dominion Bank and TD Securities Inc. For the September 30, 2026 event date, the statement reports aggregate beneficial ownership of 2,886,236 ordinary shares, or 5.9% of the class.

The ownership table assigns The Toronto-Dominion Bank sole voting and dispositive power over 2,770,530 shares (5.7%) and TD Securities Inc. sole voting and dispositive power over 115,706 shares (0.2%). The bank says it may be deemed to have an indirect interest in TD Securities’ shares through its ownership of the broker-dealer, but disclaims ownership except to the extent of its pecuniary interest.

Aggregate beneficial ownership 2,886,236 shares Joint statement; September 30, 2026 event date
Aggregate ownership percentage 5.9% Of the class, per the joint statement
The Toronto-Dominion Bank beneficial ownership 2,770,530 shares Sole voting and dispositive power; 5.7% of the class
TD Securities Inc. beneficial ownership 115,706 shares Sole voting and dispositive power; 0.2% of the class
beneficially owned regulatory
"Amount beneficially owned: 2,886,236"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Joint Filing Agreement regulatory
"Exhibit I JOINT FILING AGREEMENT"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many URGN shares do TD Bank and TD Securities report owning?

The joint statement reports 2,886,236 shares, or 5.9% in aggregate. Its ownership table lists 2,770,530 shares for The Toronto-Dominion Bank and 115,706 for TD Securities Inc.

Does TD Bank claim TD Securities’ URGN shares as its own?

TD Bank says it may be deemed to have an indirect interest in TD Securities’ 115,706 shares because it owns TD Securities, but disclaims ownership of those shares except to the extent of its pecuniary interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





M96088105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



The Toronto-Dominion Bank
Signature:Christina Petrou
Name/Title:Christina Petrou / Executive Vice President & Chief Operating Officer
Date:11/13/2026
TD SECURITIES INC.
Signature:Jason Chen
Name/Title:Jason Chen / Senior Vice President - Global Operations and Business Services
Date:11/13/2026
Exhibit Information

Exhibit I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the ordinary shares of UroGen Pharma Ltd. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: November 13, 2026 THE TORONTO-DOMINION BANK By: /s/ Christina Petrou Title: Executive Vice President & Chief Operating Officer TD SECURITIES INC. By: /s/ Jason Chen Title: Senior Vice President - Global Operations and Business Services

Keep reading